Myriad Genetics (MYGN) EndoPredict Secures Positive Coverage Decisions from Medicare & Anthem (ANTM)
Tweet Send to a Friend
Myriad Genetics, Inc. (NASDAQ: MYGN), the Medicare contractor who oversees the MolDx program and Anthem, Inc. (NYSE: ATNM) one of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
